Zentalis Pharmaceuticals, Inc.·4

Feb 10, 9:41 AM ET

Kariuki Enoch 4

4 · Zentalis Pharmaceuticals, Inc. · Filed Feb 10, 2021

Insider Transaction Report

Form 4
Period: 2021-02-09
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-09+42,00042,000 total
    Exercise: $39.47Exp: 2031-02-08Common Stock (42,000 underlying)
Footnotes (1)
  • [F1]The options vest and become exercisable in substantially equal monthly installments over the 36 months following the date of grant.

Documents

1 file
  • 4
    wf-form4_161296807661323.xmlPrimary

    FORM 4